India Cracks Down on Direct-to-Public Ads for Weight-Loss Prescription Drugs

SUMMARY

AI Generated Content
  • India’s CDSCO banned direct weight-loss drug ads, citing misuse.
  • GLP-1 drugs must be prescribed; promotion risks regulatory action.
  • Firms must now focus on lifestyle changes, not drug-led weight loss.
AD
AD